New fears over e-cigarettes after study finds they affect the lungs in a similar way to tobacco
- Electronic cigarettes may not be as safe as first thought
- Scientists grew bronchial cells exposed to vapour and tobacco smoke
- Lung cells develop similar mutations when exposed to e-cig vapor
- This means they might be 'safer' than cigarettes, but not harmless
- Sales of e-cigarettes increased by 340 per cent in Britain alone last year
E-cigarettes have been touted as a ‘safer’ alternative for smokers, but a new study indicates that this may not be the case. Sales
of e-cigarettes have soared by 340 per cent in the past year as Britons
turn to the electronic smoking devices in a bid to quit traditional
cigarettes. Now, a study
examining the biological effects of e-cigarettes found ‘strikingly
similar’ gene mutations in lung cells exposed to e-cig vapour as those
found in smokers.
Scientists grew
bronchial cells in mediums exposed to e-cig vapour and compared them to
bronchial cells grown in a medium exposed to tobacco smoke. They found that the gene mutations in both sets of cells, although not identical, showed ‘striking similarities’.
‘[E-cigarettes] may be safer,
but our preliminary studies suggest that they may not be benign,’ said
study author Avrum Spira, a genomics and lung cancer researcher at
Boston University. This
means that although e-cigarette vapour is tobacco and tar-free and that
the device does not require combustion, it could potentially increase a
user’s risk of cancer. Mr
Spria, who presented the study’s findings at the American Association of
Cancer Research’s annual meeting this week, said he could not confirm
or deny that e-cigarettes cause cancer, as the research is in its early
stages. Further experiments are planned.
E-cigarettes have soared
in popularity in recent years as consumers look for ‘healthier’ ways to
continue smoking, rather than use gum or patches to quit the habit. Figures released last month found that while sales of smoking quitting aids have slowed, the market for e-cigarettes is booming. Sales have increased by 340 per cent over the past year, from £44 million in 2012 to reach an estimated £193 million in 2013. The
report says that while the smoking cessation market has seen strong
growth historically, with annual increases of around 6-10 per cent
between 2009-12, sales of products such as gum, tablets and patches have
slowed. In 2013 the market for smoking cessation aids grew just 1.7 per cent to reach a value of £131 million.
No comments:
Post a Comment